Tourmaline Bio Inc. (TRML) Stock Analysis

Tourmaline Bio Inc. (TRML) is a publicly traded company in the HEALTHCARE sector. It trades at $47.98, carries a market capitalization of $1.23B. This page summarizes the public market data, fundamentals, and frequently asked questions for TRML, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $47.98
• Market Cap: $1.23B
• EPS: $-3.44
• 52-Week High: $48.27
• 52-Week Low: $15.45

About Tourmaline Bio Inc.

None

GNG Research Analysis

GNG Research scores Tourmaline Bio Inc. (TRML) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TRML.

Frequently Asked Questions

Does TRML pay dividends?

Tourmaline Bio Inc. (TRML) does not currently pay a regular dividend.

What is TRML's market cap?

Tourmaline Bio Inc. (TRML) has a market capitalization of $1.23B with a current stock price of $47.98.